Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 2;5(4):100316.
doi: 10.1016/j.infpip.2023.100316. eCollection 2023 Dec.

Re-purposed drive-through vaccination set-up for Mpox, New York Metropolitan Area

Marina Keller  1 , Vishnu Chaturvedi  1 , Rebecca Glassman  1 , Donald S Chen  1 , Marc El-Khoury  1 , Mary Dundas  1 , Nicholas Feola  1 , Varghese Thankachen  1 , Marie Yezzo  1 , Keri Tone  1 , Justin Williams  1 , Renee Garrick  1
Affiliations

Re-purposed drive-through vaccination set-up for Mpox, New York Metropolitan Area

Marina Keller et al. Infect Prev Pract. .

Abstract

Background: This report details how one large medical center in the Metropolitan New York area re-purposed a drive-through COVID-19 vaccination structure to handle a surge in Mpox cases in July 2022.Methods/Results: Simultaneous to on-going COVID -19 vaccination and testing, Mpox vaccination was rolled out in the same drive through structure. More than 1,820 Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) vaccine dosages were delivered subcutaneously and then intradermally to 1,123 individuals through the open window of their vehicles, averaging 8-10 patients an hour. Five vaccine recipients suffered Mpox rash; there was no exposure among healthcare providers.

Conclusion: Drive-through vaccination is an efficient model to be redeployed for future unexpected vaccine initiatives.

Keywords: Epidemic surge; Intradermal; Jynneos; Monkeypox; Mpox; Vaccine drive-through.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Other acknowledgements: Jynneos ® – smallpox and monkeypox vaccine, live, nonreplicating, manufactured by Bavarian Nordic, Kvistgaard, Denmark.

Figures

Figure 1
Figure 1
Drive through structure.
Figure 2
Figure 2
(a) Drive through structure – Three lanes for patients driving through and one lane for pedestrians are illustrated. COVID-19 testing occupied lane 2, COVID-19 vaccinations were lane 3, while Mpox vaccination happened in lane 4. The 8 wide open garage doors provided ample ventilation for the unit. Four HVAC units provided either air conditioning or heating for the healthcare workers, with 8 over head outflow vents (b) Site structure- drive through located approximately 150 yards from a public bus stop.
Figure 3
Figure 3
Jynneos screening questions.
See this image and copyright information in PMC

References

    1. WHO . World Health Organization; Geneva: 2022. Multi-country outbreak of monkeypox. External situation report.https://www.who.int/publications/m/item/multi-country-outbreak-of-monkey... Published: November 15, 2022.
    1. CDC . Centers for Disease Control and Prevention; Atlanta: 2022. 2022 Outbreak cases and data.https://www.cdc.gov/poxvirus/monkeypox/response/2022/index.html Updated: May31, 2023.
    1. NYSDOH . New York State Department of Health; Albany: 2022. Health Advisory: Monkeypox cases not associated with travel to areas where monkeypos is Enzootic.https://www.health.ny.gov/diseases/communicable/zoonoses/monkeypox/docs/... Published: July 8, 2022.
    1. Mpox Equity and anti-stigma toolkit. Centers for Disease Control; Atlanta: 2023. https://www.cdc.gov/poxvirus/monkeypox/resources/toolkits/vaccine-equity... Published: March 16, 2023.
    1. Resnick-Ault D., Wendel S.K., Skaggs M.D., White S., Zane R.D. Drive-through efficiency:how to prepare for and execute a mass-vaccination event. New England J Medicine Catalyst Innovat Care Delivery. 2021;2(2) https://catalyst.nejm.org/doi/full/10.1056/CAT.21.0058 - DOI